4 news items
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SABS
6 May 24
, low dose of rabbit ATG has demonstrated the ability to modulate the body's immune response to help slow beta cell destruction and preserve the ability
SAB Biotherapeutics Provides SAB-142 Trial Update
SABS
16 Apr 24
the ability to modulate the body's immune response to help slow beta cell destruction and preserve the ability of these cells to generate insulin, which
SAB Biotherapeutics Announces Clinical Partnership With Naval Medical Research Center To Advance Potential Influenza Treatment
SABS
25 Mar 24
to the CDC, influenza causes substantial morbidity and mortality worldwide despite available antivirals and vaccines. Influenza is responsible
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
SABS
25 Mar 24
and vaccines. Influenza is responsible for approximately 226,000 excess hospitalizations and 30,000 to 50,000 deaths each year in the United States
- Prev
- 1
- Next